HLG Genomics Lists on KOSDAQ on July 24 at 21,500 Won Per Share

According to Yonhapnews, on July 24, HLG Genomics, a high-value active pharmaceutical ingredient (API) producer, listed on South Korea's KOSDAQ market, raising approximately 55.1 billion Korean won at 21,500 won per share. The company recorded 19 consecutive years of profitability, with last year's revenue of 28.9 billion won and operating profit of 9.3 billion won, reflecting an average operating margin of 32.3% over the past three years. The institutional investor roadshow garnered a 714.52-to-1 subscription rate.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments